🔎 Trials Near Me

Beranda › Neuropati Sensorik dan Otonom Herediter › Virginia

Uji klinis Neuropati Sensorik dan Otonom Herediter di Virginia

7 studi untuk Neuropati Sensorik dan Otonom Herediter mencari peserta di lokasi di Virginia.

Kota di Virginia

Teks studi resmi (Bahasa Inggris)

Study of ACR-2316 in Specific Advanced Solid Tumors

  • Next Virginia, Fairfax
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06667141

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, Fairfax
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07749586

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • USO-Virginia Cancer Specialists, PC, Fairfax
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • NEXT, Fairfax
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06993844

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

  • Virginia Cancer Specialists, Fairfax
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 22 Apr 2026 · NCT05683418

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

  • Virginia Cancer Specialists, P.C., Fairfax
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 24 Des 2025 · NCT06463028

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.